| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |